Streetbeat News

Analyst Ratings

TGLS

Raymond James analyst Sam Darkatsh has maintained a Strong Buy rating on Tecnoglass (NYSE:TGLS), but lowered the price target from $52 to $45.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 7:15 pm

VVX

Raymond James analyst Brian Gesuale maintains a Strong Buy rating on V2X (NYSE:VVX) but has lowered the price target from $65 to $60.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 7:13 pm

CYTK

B. Riley Securities has initiated coverage on Cytokinetics (NASDAQ:CYTK) with a Buy rating and a price target of $66.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 7:10 pm

VTYX

Morgan Stanley analyst Vikram Purohit has downgraded Ventyx Biosciences from Overweight to Equal-Weight and lowered the price target from $46 to $6.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 7:06 pm

UNH

A significant bearish stance has been taken on UnitedHealth Group (NYSE:UNH) as indicated by unusual options activity. The overall sentiment of these big-money traders is split between 40% bullish and 60% bearish. The whales have been targeting a price range from $400.0 to $600.0 for UnitedHealth Group over the last 3 months. Analysts from Morgan Stanley, Jefferies, UBS, RBC Capital, and Piper Sandler have given their ratings and price targets for UNH.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 7:00 pm

INSP

Six analysts have provided ratings for Inspire Medical Systems (NYSE:INSP) in the last quarter, with four being bullish, one somewhat bullish, and one indifferent. The average price target is $265.33, representing an upside from the current price of $162.01. However, this average is a 27.21% decrease from the previous average price target of $364.50.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 7:00 pm

AMAT

A financial giant has made a bullish move on Applied Mat (NASDAQ:AMAT), with 54% of traders showing bullish tendencies and 45% bearish. The significant investors are aiming for a price territory of $100.0 to $165.0 for Applied Mat over the next three months. The trading volume stands at 2,431,459, with AMAT's price down -0.28%, positioned at $139.97. Needham has elevated its stance to Buy, setting a new price target at $180.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 7:00 pm

M

Over the past 3 months, 9 analysts have published their opinion on Macy's (NYSE:M) stock. The company has an average price target of $13.78, representing a 12.78% decrease from the previous average price target of $15.80. The analysts' ratings range from bullish to bearish, with the majority being indifferent.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 7:00 pm

MLTX

Over the past 3 months, 16 analysts have published their opinion on MoonLake (NASDAQ:MLTX) stock. The company has an average price target of $76.38, an increase of 86.29% from the previous average price target of $41.00. The majority of the analysts are bullish on the stock.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 7:00 pm

NEM

Over the past three months, five analysts have published their opinions on Newmont (NYSE:NEM) stock. Two analysts are somewhat bullish, while three are indifferent. The company has an average price target of $50.2, representing a 5.28% decrease from the previous average price target of $53.00.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 7:00 pm